PL3480200T3 - Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca - Google Patents

Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Info

Publication number
PL3480200T3
PL3480200T3 PL17820539.9T PL17820539T PL3480200T3 PL 3480200 T3 PL3480200 T3 PL 3480200T3 PL 17820539 T PL17820539 T PL 17820539T PL 3480200 T3 PL3480200 T3 PL 3480200T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
composition containing
optically active
active pyranochromenylphenol
derivative
Prior art date
Application number
PL17820539.9T
Other languages
English (en)
Inventor
Sang Ku Yoo
Jin Wook Chung
In Geun Jo
Ji Young Kim
Jeong Ho Im
Ku Suk Kang
Jin Young Kim
Original Assignee
Glaceum, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum, Inc. filed Critical Glaceum, Inc.
Publication of PL3480200T3 publication Critical patent/PL3480200T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL17820539.9T 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca PL3480200T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160081674 2016-06-29
PCT/KR2017/006863 WO2018004263A1 (ko) 2016-06-29 2017-06-29 광학 활성 피라노크로메닐페놀 유도체 및 그를 포함하는 약학적 조성물

Publications (1)

Publication Number Publication Date
PL3480200T3 true PL3480200T3 (pl) 2023-01-30

Family

ID=60787377

Family Applications (2)

Application Number Title Priority Date Filing Date
PL22153273.2T PL4023651T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca
PL17820539.9T PL3480200T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL22153273.2T PL4023651T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Country Status (17)

Country Link
US (2) US20190152984A1 (pl)
EP (2) EP4023651B1 (pl)
JP (2) JP2019520381A (pl)
KR (1) KR102388965B1 (pl)
CN (1) CN109476676B (pl)
AU (1) AU2017287746B2 (pl)
BR (1) BR112018077392A2 (pl)
CA (1) CA3028954C (pl)
DK (1) DK4023651T3 (pl)
ES (2) ES2964146T3 (pl)
IL (1) IL263826B2 (pl)
MX (1) MX393450B (pl)
PL (2) PL4023651T3 (pl)
SG (1) SG11201811796SA (pl)
TW (1) TWI731998B (pl)
WO (1) WO2018004263A1 (pl)
ZA (1) ZA201900121B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI641610B (zh) * 2016-10-04 2018-11-21 南韓商格雷森伍股份有限公司 用於合成3-苯基-2,3,4,8,9,10-六氫吡喃並[2,3-f]色烯衍生物及其光學異構物的方法
KR20200105198A (ko) * 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
US20250367163A1 (en) 2021-06-08 2025-12-04 Glaceum, Inc. Pharmaceutical composition for preventing or treating degenerative eye diseases
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물
KR20240113389A (ko) 2023-01-12 2024-07-22 주식회사 글라세움 퇴행성 골관절염의 예방 또는 치료용 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050035142A (ko) * 2001-10-11 2005-04-15 카네카 코포레이션 페록시좀 증식제 응답성 수용체 리간드제 및 그 제조 방법
TW200513194A (en) * 2003-07-31 2005-04-16 Kaneka Corp Fat and oil processed composition for prevention and/or amelioration of life-style related disease
WO2007058480A1 (en) * 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
KR101742274B1 (ko) 2014-12-31 2017-06-01 주식회사 과학기술분석센타 소규모 상수시설 통합 관리 시스템의 수질 측정 장치
TWI641610B (zh) * 2016-10-04 2018-11-21 南韓商格雷森伍股份有限公司 用於合成3-苯基-2,3,4,8,9,10-六氫吡喃並[2,3-f]色烯衍生物及其光學異構物的方法

Also Published As

Publication number Publication date
BR112018077392A2 (pt) 2019-04-09
EP4023651A1 (en) 2022-07-06
CN109476676B (zh) 2021-09-17
EP3480200B1 (en) 2022-10-19
PL4023651T3 (pl) 2024-02-19
JP2019520381A (ja) 2019-07-18
EP3480200A4 (en) 2020-02-26
JP7036871B2 (ja) 2022-03-15
TW201808961A (zh) 2018-03-16
NZ749461A (en) 2020-08-28
ES2964146T3 (es) 2024-04-04
AU2017287746A1 (en) 2019-01-17
MX2018016361A (es) 2019-09-16
MX393450B (es) 2025-03-24
CN109476676A (zh) 2019-03-15
ZA201900121B (en) 2023-04-26
ES2929931T3 (es) 2022-12-05
US20210094967A1 (en) 2021-04-01
IL263826A (en) 2019-01-31
US11332475B2 (en) 2022-05-17
CA3028954A1 (en) 2018-01-04
US20190152984A1 (en) 2019-05-23
DK4023651T3 (da) 2023-11-20
SG11201811796SA (en) 2019-02-27
TWI731998B (zh) 2021-07-01
EP3480200A1 (en) 2019-05-08
CA3028954C (en) 2020-10-27
KR20180002539A (ko) 2018-01-08
WO2018004263A1 (ko) 2018-01-04
KR102388965B1 (ko) 2022-04-22
EP4023651B1 (en) 2023-09-13
AU2017287746B2 (en) 2020-04-09
JP2020186259A (ja) 2020-11-19
IL263826B1 (en) 2023-01-01
IL263826B2 (en) 2023-05-01

Similar Documents

Publication Publication Date Title
IL260383B (en) Low dose therapeutic treatment
EP3513809A4 (en) MEDICAL COMPOSITION
EP3454899C0 (en) PHARMACEUTICAL COMPOSITION
EP4233846C0 (en) PHARMACEUTICAL FORMULATIONS
DK3655017T3 (da) Farmaceutisk sammensætning
EP3641771A4 (en) PHARMACEUTICAL COMPOSITIONS
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
BR112017016465A2 (pt) composto heterocíclico e composição farmacêutica que o compreende
EP3541385A4 (en) PHARMACEUTICAL FORMULATIONS
MA42303A (fr) Formulations pharmaceutiques
DK3634377T3 (da) Farmaceutisk formulering
MA43705A (fr) Formulation pharmaceutique
EP3437644A4 (en) MEDICINE
MA44987A (fr) Formulations de médicaments améliorées
EP3402470A4 (en) STABLE PHARMACEUTICAL COMPOSITION
EP3583943A4 (en) PHARMACEUTICAL COMPOSITION
EP3527216A4 (en) MEDICINE
EP3383371C0 (en) PHARMACEUTICAL FORMULATION
IL263826A (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
DK3280447T3 (da) Farmaceutiske formuleringer
EP3337463A4 (en) PHARMACEUTICAL FORMULATIONS
EP3646867C0 (en) PHARMACEUTICAL COMPOSITION
DK3463365T3 (da) Farmaceutisk antifungal formulering
DK3432887T3 (da) Anti-tuberkulosemiddel
EP3727485C0 (en) PHARMACEUTICAL COMPOSITION